Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal Carbon Dioxide for Moderate to Severe Migraine
NCT01253915Phase 2Terminated
- Sponsor
- Capnia, Inc.
- Start
- Jan 2012
- Primary completion
- Apr 2013
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in migraine comparing Carbon Dioxide with Placebo (2 arms). Primary endpoint: Proportion of patients who are pain-free at 2 hours. Started Jan 2012; status: terminated.
02
Drugs
Carbon dioxide
03
Conditions
migraine
Beyond the preview
Go deeper on NCT01253915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01253915.